/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

IM CANNABIS CORP

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$1.65 -0.0343(-3.43%) IMCC at 04 Dec 2025 04:35 PM Drug Manufacturers - Specialty & Generic
Lowest Today 1.68
Highest Today 1.73
Today’s Open 1.707
Prev. Close 1.75
52 Week High 7.12
52 Week Low 0.93
Day’s Range: Low 1.68 High 1.73
52-Week Range: Low 0.93 High 7.12
1 day return -
1 Week return -5.08
1 month return +34.4
3 month return -16.83
6 month return -43.81
1 year return -40.84
3 year return -14.72
5 year return -
10 year return -

Institutional Holdings

AdvisorShares Investments, LLC 2.00

AdvisorShares Pure Cannabis ETF 2.00

Heron Bay Capital Management 1.50

Citadel Advisors Llc 0.23

Bank of Montreal 0.23

BMO Capital Markets Corp. 0.23

Virtu Financial LLC 0.21

FNY Investment Advisers, LLC 0.10

Federation des caisses Desjardins du Quebec 0.04

Ninepoint Alternative Health A 0.02

Royal Bank of Canada 0.00

Advisor Group Holdings, Inc. 0.00

Bryn Mawr Trust Company 0.00

TD Waterhouse Canada Inc 0.00

Park Square Financial Group, LLC 0.00

UBS Group AG 0.00

Group One Trading, LP 0.00

Kiker Wealth Management, LLC 0.00

SBI Securities Co Ltd 0.00

Market Status

Strong Buy: 0

Buy: 0

Hold: 1

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 9.18 M

PB Ratio 3.7463

PE Ratio 0.0

Enterprise Value 20.08 M

Total Assets 39.19 M

Volume 44060

Company Financials

Annual Revenue FY23:52535000 52.5M, FY22:54335000 54.3M, FY21:54300000 54.3M, FY20:15890000 15.9M, FY19:9074000 9.1M

Annual Profit FY23:9854000 9.9M, FY22:9162000 9.2M, FY21:10296000 10.3M, FY20:10468000 10.5M, FY19:3929000 3.9M

Annual Net worth FY23:-63252000 -63.3M, FY22:-24921000 -24.9M, FY21:-18518000 -18.5M, FY20:-28734000 -28.7M, FY19:-7419000 -7.4M

Quarterly Revenue Q3/2025:13851000 13.9M, Q2/2025:12696000 12.7M, Q1/2025:12500000 12.5M, Q3/2024:13883000 13.9M, Q2/2024:14750000 14.8M

Quarterly Profit Q3/2025:2731000 2.7M, Q2/2025:3425000 3.4M, Q1/2025:3448000 3.4M, Q3/2024:3148000 3.1M, Q2/2024:844000 0.8M

Quarterly Net worth Q3/2025:-3651000 -3.7M, Q2/2025:-309000 -0.3M, Q1/2025:275000 0.3M, Q3/2024:-922000 -0.9M, Q2/2024:-3029000 -3.0M

Fund house & investment objective

Company Information IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and cannabis extracts under the IMC, BLKMT, WAGNERS, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Tel Aviv, Israel.

Organisation Drug Manufacturers - Specialty & Generic

Employees 0

Industry Drug Manufacturers - Specialty & Generic

CEO Mr. Oren Shuster

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow